×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Skip to main content
Tags: mylan | recall | epipens | expands | to US

Mylan Recall of EpiPens Reaches to 13 Lots Distributed in US

Mylan Recall of EpiPens Reaches to 13 Lots Distributed in US
(FDA)

By    |   Monday, 03 April 2017 11:20 AM EDT

The Mylan recall of the EpiPen has expanded to the U.S. after “extremely rare” defects were found in the allergy injectors, causing them to be ineffective for many users.

“The recall is being expanded to include additional lots as a precautionary measure out of an abundance of caution,” Mylan, EpiPen’s manufacturer, said in a statement, according to Bloomberg.

Mylan said it’s recalling EpiPen’s from 13 lots to be exact, but people will not have to come out of their pockets to pay for the replacement pens.

“The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies’ voluntary recall of 13 lots of Mylan’s EpiPen and EpiPen Jr. (epinephrine injection) Auto-Injector products used for emergency treatment of severe allergic reactions,” according to the FDA website. “This recall is due to the potential that these devices may contain a defective part that may result in the devices’ failure to activate. The recalled product was manufactured by Meridian Medical Technologies and distributed by Mylan Specialty.”

This comes a month after Mylan announced that it would be recalling about 80,000 EpiPens in Australia, Europe, Japan, and New Zealand, according to Web MD. That was after two reports surfaced that the device had failed to deliver its dose in emergency situations.

According to Mylan, the defective part of the EpiPen causes the user to have to use additional force to activate the needle, otherwise the injector might not work at all.

The recall in the U.S. will apply to EpiPen and EpiPen Jr. Injectors that were distributed between December 17, 2015, to July 1, 2016.

EpiPen users can also contact Mylan directly at 800-796-9526 or at customer.service@mylan.com if they have any questions or concerns.

© 2022 Newsmax. All rights reserved.


TheWire
The Mylan recall of the EpiPen has expanded to the U.S. after “extremely rare” defects were found in the allergy injectors, causing them to be ineffective for many users.
mylan, recall, epipens, expands, to US
285
2017-20-03
Monday, 03 April 2017 11:20 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved